The DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
An Update of Congenital Adrenal Hyperplasia
Abstract
Congenital adrenal hyperplasia (CAH) is a family of autosomal recessive disorders caused by mutations that encode for enzymes involved in one of the various steps of adrenal steroid synthesis. These defects result in the absence or the decreased synthesis of cortisol from its cholesterol precursor. The anterior pituitary secretes excess adrenocorticotrophic hormone (ACTH) via feedback regulation by cortisol, which results in overstimulation of the adrenals and causes hyperplasia. Symptoms due to CAH can vary from mild to severe depending on the degree of ensymatic defect. In the classical form of CAH, there is a severe enzymatic defect owing to mutations in the CYP21 gene. Classically affected female fetuses undergo virilization of the genitalia prenatally and present with genital ambiguity at birth; however, prenatal treatment of CAH with dexamethasone to prevent ambiguity has been successfully utilized for over a decade. In the less severe, late-onset form of CAH, prenatal virilization does not occur. The milder enzyme deficiency was termed nonclassical 21-hydroxylase deficiency (NC21OHD) in 1979 and was later found to be the most common autosomal recessive disorder in humans. Disease frequency of NC21OHD varies between ethnic groups with the highest ethnic-specific disease frequency in Ashkenazi Jews at 1/27. NC21OHD is diagnosed by serum elevations of 17-OHP that plot on a nomogram between the range for unaffected individuals and levels observed for classical CAH and is typically confirmed with molecular genetic analysis. Similar to classical CAH, nonclassical 21-hydroxylase deficiency may cause premature development of pubic hair, advanced bone age, accelerated linear growth velocity and diminished final height in both males and females. Severe cystic acne has also been attributed to nonclassical CAH. Women may present with symptoms of androgen excess, including hirsutism, temporal baldness, and infertility. Menarche in females may be normal or delayed and secondary amenorrhea is a frequent occurrence. Polycystic ovary syndrome may also be seen in these patients. In males, early beard growth, acne, and growth spurt may prompt the diagnosis of NC21OHD. Although many males appear to be asymptomatic, they may present with oligozoospermia or diminished fertility. Individuals presenting to dermatology and infertility clinics with symptoms of hyperandrogenemia are rarely screened for NC21OHD. However, with hormonal and molecular genetic screening, previously undiagnosed patients may be identified and can therefore receive glucocorticoid treatment, which has been shown to reverse symptoms within 3 months.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgens have a central role in acne, since acne onset is correlated with adrenarchal rise of blood DHEA-S levels [194], it manifests in congenital adrenal hyperplasia [195], is seen during hyperadrogenism in women [196], and it develops during anabolic steroid administration [197].”
From Steroidogenesis in the skin: Implications for local immune functions (2013) · cites this paper as [195]
Citations
Cites
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91513-6 · Cited by 1,070
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis
Lin, D., Sugawara, T., Strauss, J. F., Clark, B. J., Stocco, D. M., Saenger, P., Rogol, A., & Miller, W. L. (1995) · Science · doi:10.1126/science.7892608 · Cited by 1,030
The pathophysiology and genetics of congenital lipoid adrenal hyperplasia
Bose, H. S., Sugawara, T., Strauss, J. F., & Miller, W. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352503 · Cited by 676
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Self-citationSpeiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Self-citationStructure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
17-Hydroxylation deficiency in man
Biglieri, E. G., Herron, M. A., & Brust, N. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105499 · Cited by 561
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555
GENETIC POLYMORPHISM IN HUMAN GLYCINE-RICH BETA-GLYCOPROTEIN
Alper, C. A., Boenisch, T., & Watson, L. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.135.1.68 · Cited by 524
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Research works printed but not linked: 23
- Crecchio L., 1865, Sopra un caso di apparenzi virili in una donna, Morgagni, 7, 154
- Ganong W. 1963. The central nervous system and the synthesis and release of adrenocorticotrophic hormone.InAdvances in Neuroendocrinology. A. Nalbandov Ed.: 92. University of Illinois Press. Urbana.
- Guillemin R. & A. Schally. 1963. Recent advances in the chemistry of neuroendocrine mediators originating in the central nervous system.InAdvances in Neuroendocrinology. A. Nalbandov Ed.: 314. University of Illinois Press. Urbana.
- 10.1210/jc.84.12.4410 · DOI · Paper page
- 10.1210/jc.79.6.1811 · DOI
- 10.1210/jc.81.2.482 · DOI
- New M. & L. Levine. 1981. Adrenal hyperplasia in intersex states.InPediatric and Adolescent Endocrinology. Z. Laron & P. Tikva Eds. Vol.8:51. S. Karger. Basel.
- Decourt M.J., 1957, Virilisme cliniquement tardif avec excretion de pregnanetriol et insuffisance de la production du cortisol, Ann. Endocrinol. (Paris), 18, 416
- 10.1210/jc.74.2.248 · DOI
- New M.I. J.M. Gertner P.W. Speiser & P. del Balzo. 1991. Growth and final height in congenital adrenal hyperplasia (classical 21‐hydroxylase deficiency) and in nonclassical 21‐hydroxylase deficiency.InGrowth Disorders: The State of the Art. L. Cavallo J.C. Job & M.I. New Eds. Vol.81:105–110. Raven Press. New York City.
- 10.1210/jc.74.3.685 · DOI · Paper page
- Wentz A. S. Garcia G. Klingensmith et al.1977. Hypothalamic maturation in congenital adrenal hyperplasia.InCongenital Adrenal Hyperplasia. P. Lee L. Plotnick A. Kowarski & C. Migeon Eds.: 379. University Park Press. Baltimore.
- Kirkland R. B. Keenan & G. Clayton. 1977. Long‐term follow‐up of patients with congenital adrenal hyperplasia in Houston.InCongenital Adrenal Hyperplasia P. Lee L. Plotnick A. Kowarski & C. Migeon Eds.: 273. University Park Press. Baltimore.
- Mori M., 1970, Congenital adreogenital syndrome and successful pregnancy: report of a case, J. Obstet. Gynecol., 35, 394
- Wilkins L. 1965. The Diagnosis and Treatment of Endocrine Disorders. Charles C. Thomas. Springfield IL pp. 368–381.
- Raiti S. N. Maclaren & F. Akesode. 1977. Gonadotropin‐adrenal‐testicular axis in males with congenital adrenal hyperplasia and idiopathic sexual precocity.InCongenital Adrenal Hyperplasia. P. Lee L. Plotnick A. Kowarski & C. Migeon Eds.: 403. University Park Press. Baltimore.
- 10.1210/jc.77.1.86 · DOI
- 10.1210/me.6.8.1211 · DOI · Paper page
- Josso N. 2001. Anatomy and endocrinology of fetal sex differentiation. In Endocrinology. L. DeGroot and J. Jameson Eds.: 1947–1954. W.B. Saunders Company. Philadelphia PA.
- Wilson R.C.et al.1995. Rapid DNA analysis by allele‐specific PCR for detection of mutations in the steroid 21‐hydroxylase gene. J. Clin. Endocrinol. Metab.80(5): 1635–1640. · DOI
- 10.1210/jc.83.11.3872 · DOI · Paper page
- 10.1210/jc.80.7.2014 · DOI
- Bartter F. 1977. Adrenogenital syndromes from physiology to chemistry.InCongenital Adrenal Hyperplasia. P. Lee L.P. Plotnick A. Kowaraski & C. Migeon Eds.: 9. University Park Press. Baltimore.
Cited by
Sorted by citations
Zouboulis, C., Chen, W.-C., Thornton, M., Qin, K., & Rosenfield, R. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-961807 · Cited by 379
Steroidogenesis in the skin: Implications for local immune functions
Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.006 · Cited by 369
Cutaneous androgen metabolism: basic research and clinical perspectives
Chen, W., Thiboutot, D., & Zouboulis, C. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00613.x · Cited by 273
Androgens and androgen receptor action in skin and hair follicles
Ceruti, J. M., Leirós, G. J., & Balañá, M. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.009 · Cited by 219
Völkl, T. M. K., Simm, D., Beier, C., & Dörr, H. G. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1005 · Cited by 184
Metadata
- Authors
- NEW, M. I.
- Affiliations
- Mount Sinai Hospital (US)
- Corresponding author
- NEW, MARIA I.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 1038
- Issue
- 1
- Pages
- 14-43
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2095619793
- Cited by
- 178
- References
- 417
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 16 · 2019: 3 · 2018: 2 · 2017: 6 · 2016: 10 · 2015: 4 · 2014: 7 · 2013: 12 · 2012: 7
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21, ambiguous genitalia, 17-hydroxyprogesterone, hyperandrogenism, infertility, polycystic ovary syndrome, Ashkenazi Jews, molecular genetic screening, enzyme replacement therapy
- MeSH terms
- Adrenal Hyperplasia, Congenital, Female, Genotype, Hormones, Humans, Male, Menstruation, Prenatal Diagnosis, Puberty, Steroid 21-Hydroxylase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review